Allosteric Bioscience

Allosteric Bioscience is a verifiable early-stage biotech company (founded ~2021) leveraging quantum computing and AI for longevity and sarcopenia treatments, with documented partnerships (e.g., Johns Hopkins, PolarisQB). However, the project submission itself is of extremely low quality, containing demonstrably false claims (e.g., 'most people have used my product' for a pre-clinical company) and vague data ('everyone', 'null'). While the technology and market focus are promising, the lack of verifiable user traction and the unprofessional submission significantly depress the score.